Investor Relations

CAMBRIDGE, Mass., Dec 07, 2006 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a company developing and commercializing environmentally sustainable and totally biodegradable Natural Plastic, announced today that the Company has named Matthew Strobeck, Ph.D. and Robert L. Van Nostrand to its Board of Directors.

Matthew Strobeck, Ph.D., is a senior investment analyst at Westfield Capital Management, specializing in healthcare and life sciences. Dr. Strobeck previously served as a consultant to the senior economic advisor to the commissioner of the Food and Drug Administration (FDA). Prior to his work with the FDA, Dr. Strobeck was a fellow in the Department of Biology at the Massachusetts Institute of Technology. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, a S.M. from Harvard University and a S.M. from the Massachusetts Institute of Technology Sloan School of Management.

"Dr. Strobeck's insights as a professional life science investor will be extremely valuable in helping Metabolix strategically manage our technology portfolio to best realize the economic potential of our scientific opportunities," said Jim Barber, president and CEO of Metabolix.

Robert L. Van Nostrand is the Senior Vice President and Chief Compliance Officer of OSI Pharmaceuticals, Inc., a biotechnology company focused on developing therapeutics for cancer, eye disease and diabetes. Mr. Van Nostrand has been with OSI for almost twenty years, previously serving as the Vice President and Chief Financial Officer from 1996 through 2005. Mr. Van Nostrand also served as Vice President, Finance and Administration and OSI's Treasurer and Secretary, and prior to that, as Controller and Chief Accounting Officer. Prior to joining OSI, Mr. Van Nostrand was in a managerial position with Touche Ross & Co. (currently Deloitte and Touche). Mr. Van Nostrand serves on the board of directors of Apex Bioventures, Inc., a special purpose acquisition company focused in life sciences, and upon Apex's initial public offering, Mr. Van Nostrand will serve as Chairman of its audit committee. Mr. Van Nostrand received a B.S. in Accounting from Long Island University, New York, and completed advanced management studies at the Wharton School. Mr. Van Nostrand is a Certified Public Accountant.

"Given the depth of his experience and expertise, we are very fortunate to have Robert assuming the leadership of our audit committee as we establish ourselves as a newly public company and pursue implementing very best practice in our financial reporting and corporate compliance," continued Barber.

Dr. Strobeck will serve as a member of the compensation committee and Mr. Van Nostrand will serve as a chairman of the audit committee.

Metabolix Natural Plastic can be used as alternatives to petrochemical plastics in a wide variety of applications, including coated paper, film or bags, and thermoformed and molded goods. They are produced using a fully biological fermentation process that converts agricultural raw materials such as corn sugar into a versatile range of plastics with excellent durability in use but that also biodegrade benignly in a wide range of environments, including marine and wetlands. The company was awarded the Presidential Green Chemistry Award by the U.S. EPA in 2005 for its pathbreaking production technology. In March 2006, Archer Daniels Midland Company and Metabolix announced plans to build a 110 million pound commercial plant for its Natural Plastic in Clinton, Iowa, with start-up targeted in 2008. The company is currently in pilot production, developing applications with selected customers.

About Metabolix

Founded in 1992, Metabolix, Inc. is developing and commercializing environmentally sustainable and totally biodegradable Natural Plastic as a clean alternative to petroleum-based plastics. The Company is taking a systems approach, from gene to end product, to integrate sophisticated biotechnology with current industrial practice to produce plastics, fuels and chemicals from renewable resources. In addition to its microbial fermentation platform for production of Natural Plastic, Metabolix is also developing a proprietary platform technology for co-producing, in non-food plant crops such as switchgrass, Natural Plastic and biomass for biofuels such as ethanol and for chemical products. For more information, please visit www.metabolix.com. (MBLX-G)

SOURCE: Metabolix, Inc.

Integrated Corporate Relations for Metabolix
Jackie Kolek, 203-682-8200
Jackie.kolek@icrinc.com

Copyright Business Wire 2006

News Provided by COMTEX